Get started

Biotechnology

Pfizer and BioNTech Dose First Participants in the U.S. Hey fellow Traders from TradingView, this is an update to the actual Situation and my previous Analysis If you agree with my Analysis or find it useful , please leave me a like for my work it would be greatly appreciated. Im still bullish and optimistic that BNTX participation will have a huge global impact. The stock seems to be news related, so expect it to make huge moves when they finally will announce to have completed those first worldwide clinical studies. The Moving Averages are lining up and signalizing us there will soon be a Price expansion. Assuming the 55 MA line serves as a support we cacn expect the stock to bounce off that and rise to the resistance battleground area. I´d place my Stop Loss below the next support pivot at either 36.85 to not risk gettiong shaken out before the upcoming outbreak. If you can handle that amount of risk. If not a LOD SL is always a great way to reduce risk. Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. This U.S. trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. "The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates, and is to be evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S. will enroll up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with a given dose level of a vaccine candidate once testing of that candidate and dose level in younger adults has provided initial evidence of safety and immunogenicity. Sites currently dosing participants include NYU Grossman School of Medicine and the University of Maryland School of Medicine. The University of Rochester Medical Center/Rochester Regional Health and Cincinnati Children’s Hospital Medical Center will begin enrollment shortly." Source by: NASDAQ:BNTX FWB:22UA investors.biontech.de Remember, this is only my opinion after considering all facts and informing myself about the Up/Downside of this stock. So no financial advise is given here. Always do your own reasearch. Thank you for taking the time and i hope to see you again in my next post! See you there Sincerly, Sebastian - TradingExperts Europe
NASDAQ:BNTXLong
by Sebastian-TradingExpertsEU
6
$DVAX can rise in the next daysContextual immersion trading strategy idea. Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. The demand for shares of the company looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $3,94; stop-loss — $3,80. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:DVAXLong
by KozakHlib
Bullish Technical Setup provided by ALEC / Through 26NASDAQ:ALEC Hey Guys, today i´d like to showcase you a sharp ooking Long Setup for a shorter time frame. We are looking here at an uplifting and trending Bio TECH Stock that has shows previous Strenght when the market had its weakness. Alector, Inc. operates as a clinical-stage biopharmaceutical company. They are developing therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. No real profits are yet achieved for the Company but it still has a solid looking balance sheet. ALEC had a appropriate Consolidation Phase last week where it bounced back multiply times from the 26$ Resistance Level. Looking at the Hourly the Stock set ups very well it its given Range The Moving Averages dispaly that the Stock should be ready for a breakout expansion with a confirmation from high Volume following through. My Entry would be at 26.10 to not get trapped. Targets are 30, 32 and 36 I´d set my SL at LOD and then trail it with a 15min candel upwards to not give back any gains. This is only my opinion on technical Analysis and not a buy or sell recommendations. Do your own research before jumping into a bandwagon. Please leav me a like or a comment if you want to see more of my Analysis ! It would mean a lot to me and id´be greatly appreciated. Thanks, Sebastian - TradingExperts EU
NASDAQ:ALECLong
by Sebastian-TradingExpertsEU
MJ Trending UpETFMG Alternative Harvest (NYSE: MJ ) What is ETFMG Alternative Harvest? An ETF that acceptance of various uses of the cannabis plant such as pharmaceuticals, biotechnology and life sciences, JesusTrade Score: Buy Scale Score: Low (3/10) Portfolio Hold: Yearly Hold Fundamental Reasoning: The following below are the top 10 holding for MJ: GW Pharmaceuticals PLC Sponsored ADR (GWPH) Aphria Inc (APHA) Aurora Cannabis Inc. (ACB) MediPharm Labs Corp. (MEDIF) Cronos Group Inc (CRON) Corbus Pharmaceuticals Holdings Inc (CRBP) OrganiGram Holdings Inc (OGI) Canopy Growth Corporation (CGC) Tilray, Inc. (TLRY) Swedish Match AB (SWMAF) All of these but Tilray and Swedish Match have bullish diverange and have broke out. Tilray could just follow the hype of the other stocks and Swedish Match has been having an up trend since March of 2009 and has about $30 more to run. With mojirty of these stocks being worth less than $10 or even $5. I don't see why the volume wouldn't be coming in. On google trends there an increase of cannabis and cannabis companies being searched. which gives me a idea that new buyers could be coming.
AMEX:MJLong
by Jesus_Trade
Biontech AG Outbreak - First COVID-19 human vaccine trial test Hey fellow Trader, The uprising Biotechnology company from NASDAQ:BNTX Mainz, Germany is on its final steps from developing a vaccine for the actual Bio-weapon health crisis from the "new flu" . With Rolf Zinkernagel a brilliant Scientiests that can proudly say to win a nobelprice and a strong financial background , from big names in the Pharmaceutical field. When BioNTech AG announced to start with the first human vaccine tests after getting an approval in Europa , a US approval should follow shortly after also. We should expect News from those test in end May/june and if they´ve managed to create a proven vaccine afterwards im staying LONG in this Outbreak because its Trending and the Chances are high for a good R/R. A Golden Cross is forming and the Overall Stock is positive and with a low beta so less correlation risk in this given "Crazy Market" . So with a break of the 56 level we should see a strong move up. Goals are high and i think it could touch the 100 mark again with reactive move down to given support levels if they arent successful with their vaccine Therapy. STOPLOSS tight at 49,45 I hope this was helpful but it only displays my opionion and no financial adivce is given here. Sincerly, Sebastian
NASDAQ:BNTXLong
by Sebastian-TradingExpertsEU
1
MTNB - Bullish Weekly - Trade the Zones - Play the TicksI actually trade this for 15-20% gains on deep supply zones. Last time I got in was .51 so not bad if you understand where to buy in. I like the swings in this stock and has some volume. Bullish weekly at least to start off next week. Might fail right away with the resistance and the highs. Just need a solid open above .73. Still not banking on that. Just wanted to share a decent penny stock that if you know where to buy in then you can get some decent returns over and over. At least for now. "Reasons Why Long-term Faith on Matinas BioPharma Holdings, Inc. (MTNB) Could Pay Off Investors" investchronicle.com
AMEX:MTNB
by DigitalData
$MNOV can rise in the next daysContextual immersion trading strategy idea. The demand for shares of MediciNova looks higher than the supply. The company focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs. Due to the spread of COVID-19, the demand for the company`s services rose. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $4,41; stop-loss — $4,21. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:MNOVLong
by KozakHlib
$AYTU can rise in the next daysContextual immersion trading strategy idea. Aytu BioScience has a strong upward trend. The company develops and commercializes novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility. Due to the spread of the COVID-19, the demand for the company's services rose. Today Aytu BioScience received confirmation from the FDA that it may begin distribution of its COVID-19 IgG/IgM Rapid Test throughout the U.S. — finance.yahoo.com This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1,85; stop-loss — $1,65. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:AYTULong
by KozakHlib
2
9EMA Support of the Gods and Bounce to the HeavensI will keep this one simple. We are closing in on a major bullish breakout. As we approach the top of the larger daily flag, you can see the smaller time frame Flat top setup. Here is the beautiful part of this pattern in pattern play. we are sitting on Super strong support of the 9EMA, Its tight Its right! That 9 EMA will help push through the Flat top for a Flat top Breakout! AND THEN!!!!! Boom that Breakout power will push us through the Flag into the unknown ( $2?? $5??? $10??? $1M?????(lol)) All we need is a Catalyst!! OH DAMN we got um incoming!!! SEE you all on the moon!! Buy BUY BUY!!
ALong
by JaxelCap